Blood Measurement of NET Transcripts (NETest) Predicts Well-Differentiated Gastroenteropancreatic NET Disease Status and Is Prognostic for Disease Progression

#1569

Introduction: A key issue in GEP-NETs is early identification and prediction of disease progression. Clinical evaluation and imaging are limited due to the lack of sensitivity and disease indolence.

Aim(s): Assess the NETest as a predictive and prognostic marker of progression in a long-term follow-up study.

Materials and methods: GEP-NETs (n=34) followed for a median 4 yrs (2.2-5.4). WHO tumor grade/stage Grade I: n=15, Grade II: n=17; 31 (91%): stage IV. Baseline and longitudinal imaging and biomarkers were available and progression defined (RECIST 1.0). NETest: qPCR and multianalyte algorithmic analysis (disease activity scaled 0-100% with low <40% and high activity risk cutoffs >80%); CgA: RIA (normal <150µg/l); PFS: Kaplan-Meier analysis.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Kidd M

Authors: Pavel M, Jann H, Prasad V, Drozdov I, Modlin I,

Keywords: PCR,

To read the full abstract, please log into your ENETS Member account.